However, psilocybin provided something more: a significant boost to quality of life. In 2021, New Atlas reported on what was then a first-of-its-kind clinical trial comparing two decidedly different ...

A new analysis of clinical trial data indicates that psilocybin, when administered alongside psychotherapy, may provide rapid ...

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional ...

Two-thirds of participants in a small-scale clinical trial said they were in complete remission from depression five years later Interviews suggest the treatment helped patients see their depression ...

The stakes are high for psilocybin clinical trials — there’s a pressing need for a more effective medical solution in the fight against depression, especially treatment-resistant depression. Of the ...

This is a small study, and scientists still need to conduct more research to understand the longterm effects of psilocybin. Psilocybin is the active ingredient in magic mushrooms. In recent decades, ...

PORTLAND, Ore. — Adults with low incomes reported lower depression following three months of psilocybin treatment in a first-of-its-kind study released Tuesday. The study conducted by the National ...

A single dose of psilocybin combined with psychological support can provide lasting relief from depression and anxiety in patients with cancer. In a phase 2 clinical trial, more than half of patients ...

Control group outcomes in randomized trials of psilocybin indicated less improvement in depression scores compared with trials of other antidepressants, according to a meta-analysis, suggesting that ...

(CNN) — The matchup: Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant escitalopram, often sold as Lexapro or Cipralex.